Good luck to all the holders of Mesoblast. I hope it goes up ten fold from here.
- Forums
- ASX - By Stock
- MSB
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-90
-
-
- There are more pages in this discussion • 758 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.025(2.53%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $784.7K | 784.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 23126 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 8295 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 204989 | 1.010 |
10 | 93987 | 1.005 |
13 | 109948 | 1.000 |
9 | 105828 | 0.995 |
11 | 719229 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 112522 | 16 |
1.025 | 68936 | 14 |
1.030 | 78088 | 13 |
1.035 | 21080 | 5 |
1.040 | 34000 | 5 |
Last trade - 10.43am 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online